Date
20 November 2018
Coalities nodig voor betere toegang tot medicijnen
Writing for the NRC, Daan van Lent covers the publication of the 2018 Access to Medicine Index. The article highlights the industry's engagement in priority R&D and the small number of companies developing vital projects.
Direct links
The piece also emphasises the importance of collaboration between large pharmaceutical companies, governments and donors to improve access to medicine for people living in poorer countries. Daan quotes Jayasree K. Iyer, Executive Director of the Access to Medicine, on the fight against malaria as a good example of such collaboration: "The common goal is to have the disease banned in 2030. The pharmaceutical companies have decided not to make any profit on the malaria drugs. That is a recipe for success."